Pennant Group Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Pennant Group şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

-0.2%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-0.2%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Recent updates

Investors Shouldn't Be Too Comfortable With Pennant Group's (NASDAQ:PNTG) Earnings

Nov 14

Is The Pennant Group, Inc. (NASDAQ:PNTG) Trading At A 34% Discount?

Nov 12

Is Now The Time To Put Pennant Group (NASDAQ:PNTG) On Your Watchlist?

Oct 06

Investors Still Waiting For A Pull Back In The Pennant Group, Inc. (NASDAQ:PNTG)

Sep 14

Investors Could Be Concerned With Pennant Group's (NASDAQ:PNTG) Returns On Capital

Dec 25

Pennant Group (NASDAQ:PNTG) Is Reinvesting At Lower Rates Of Return

Sep 02

Pennant acquires California-based Ardent Hospice and Palliative Care

Aug 16

Pennant Non-GAAP EPS of $0.14 in-line, revenue of $116.3M beats by $4.02M

Aug 08

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: PNTG şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: PNTG şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Pennant Group Piyasaya Karşı Temettü Getirisi

PNTG temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (PNTG)	n/a
Pazarın Alt %25'i (US)	1.3%
Pazarın En İyi %25'i (US)	4.2%
Sektör Ortalaması (Healthcare)	1.6%
Analist tahmini (PNTG) (3 yıla kadar)	n/a

Önemli Temettü: PNTG şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, PNTG şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: PNTG şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: PNTG herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Pennant Group Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

The Pennant Group, Inc. (NasdaqGS:PNTG) announces an Equity Buyback for $1 million worth of its shares.

Recent updates

Investors Shouldn't Be Too Comfortable With Pennant Group's (NASDAQ:PNTG) Earnings

Is The Pennant Group, Inc. (NASDAQ:PNTG) Trading At A 34% Discount?

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. Updates Earnings Guidance for the Year 2024

Price target increased by 12% to US$37.50

The Pennant Group, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Price target increased by 9.5% to US$34.50

Is Now The Time To Put Pennant Group (NASDAQ:PNTG) On Your Watchlist?

The Pennant Group, Inc. has completed a Follow-on Equity Offering in the amount of $108.5 million.

New minor risk - Shareholder dilution

The Pennant Group, Inc. has completed a Follow-on Equity Offering in the amount of $108.5 million.

The Pennant Group, Inc. has filed a Follow-on Equity Offering.

The Pennant Group, Inc. has filed a Follow-on Equity Offering.

Now 21% undervalued

Price target increased by 12% to US$33.50

Investors Still Waiting For A Pull Back In The Pennant Group, Inc. (NASDAQ:PNTG)

Now 21% undervalued

Does Pennant Group (NASDAQ:PNTG) Have A Healthy Balance Sheet?

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 20% undervalued

The Pennant Group, Inc. Updates Earnings Guidance for the Year 2024

CEO & Director notifies of intention to sell stock

The Pennant Group, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Price target increased by 7.8% to US$27.50

Independent Director exercised options to buy US$1.3m worth of stock.

The Pennant Group, Inc. acquired Nurses On Wheels, Inc.

Now 21% undervalued

Here's Why Pennant Group (NASDAQ:PNTG) Can Manage Its Debt Responsibly

Price target increased by 13% to US$24.75

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

The Pennant Group, Inc. (NasdaqGS : PNTG) acquired South Davis Community Hospital, Inc.

The Pennant Group, Inc. to Report Q1, 2024 Results on May 06, 2024

New minor risk - Shareholder dilution

The Pennant Group, Inc., Annual General Meeting, May 23, 2024

President & COO exercised options to buy US$214k worth of stock.

The Pennant Group, Inc. (NASDAQ:PNTG) Not Flying Under The Radar

Price target increased by 22% to US$19.50

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. Provides Revenue Guidance for 2024

The Pennant Group, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Pennant Group (NASDAQ:PNTG) Takes On Some Risk With Its Use Of Debt

Price target increased by 10% to US$16.00

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

the Pennant Group, Inc. Provides Earnings Guidance for the Year 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Guardian Hospice of Texas and Guardian Hospice of Oklahoma.

The Pennant Group, Inc. to Report Q3, 2023 Results on Nov 07, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Valor HospiceCare.

Price target decreased by 7.1% to US$14.25

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. to Report Q2, 2023 Results on Aug 08, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Bluebird Home Health, Bluebird Hospice, and Bluebird Home Care.

Price target decreased by 8.5% to US$15.33

The Pennant Group, Inc. Announces Jennifer Freeman Assume the Role of Senior Vice President of Strategic Partnerships

Investor sentiment deteriorates as stock falls 18%

The Pennant Group, Inc. acquired Assets Of Benefit Health Care.

The Returns On Capital At Pennant Group (NASDAQ:PNTG) Don't Inspire Confidence

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improves as stock rises 16%

Independent Chairman recently bought US$67k worth of stock

Investor sentiment improves as stock rises 20%

Is Pennant Group (NASDAQ:PNTG) A Risky Investment?

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Investors Could Be Concerned With Pennant Group's (NASDAQ:PNTG) Returns On Capital

Consensus forecasts updated

The Pennant Group, Inc. (NasdaqGS:PNTG) announces an Equity Buyback for $1 million worth of its shares.

Independent Director recently bought US$203k worth of stock

Consensus forecasts updated

Consensus forecasts updated

The Pennant Group, Inc. Announces Resignation of Derek Bunker,Chief Investment Officer, Executive Vice President and Corporate Secretary, Effective December 31, 2022

Price target decreased to US$15.40

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

The Pennant Group, Inc. Provides Earnings Guidance for the Year 2022

The Pennant Group, Inc. to Report Q3, 2022 Results on Nov 07, 2022